You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.



Each year, BCRF underwrites several grants to breast cancer researchers in partnership with Conquer Cancer, the ASCO foundation. These awards provide critical funding to both early- and mid-career investigators and support innovative projects across the spectrum of breast cancer research. 

a closeup of a pipette in a lab with a pink tone to the image

Clinical trial results presented at the American Society of Clinical Oncology’s (ASCO) annual meeting, held virtually this year, highlighted advances in precision medicine for both early- and advanced-stage breast cancers.

a screenshot of lori pierce delivering her asco president's address at this year's annual meeting

The 57th annual meeting of the American Society of Clinical Oncology (ASCO), held virtually in early June, reflected this moment in societal history with an emphasis on health equity and cancer disparities.

In June, BCRF researcher Dr. Lori Pierce began her year as president of the American Society of Clinical Oncology (ASCO), one of the most prominent professional organizations for oncology professionals and physicians in the world.

Designed graphic with Nancy LIn's headshot and call to action to click to watch the video interview

As many as half of patients diagnosed with metastatic HER2-positive breast cancer will see their cancer spread to their brain. Though brain metastases are rare, they are exceedingly difficult to treat, so breast cancer patients with “brain mets” experience poor outcomes.

an illustration of a breast tumor cell in orange against a black background

Breast cancer metastasis is a complex process—and the leading cause of breast cancer deaths. At this year’s American Society of Clinical Oncology (ASCO) virtual annual meeting, researchers presented several studies that addressed the challenges of treating metastatic breast cancer.

chemotherapy IV against blue background

Treatment optimization–balancing efficacy with toxicity–remains a clinical challenge in early-stage breast cancer and was a major focus of clinical trials featured at this year’s virtual annual meeting of the American Society of Clinical Oncology (ASCO). Below are key highlights:

Portrait of the late Dr. Bernard Fisher

The Breast Cancer Research Foundation endowed a new clinical science symposium at this year’s American Society of Clinical Oncology (ASCO) annual meeting to honor the late Dr. Bernard Fisher, a pioneering breast cancer surgeon and researcher.

Dr. Lori J. Pierce presents at ASCO's 2018 annual meeting.

The American Society of Clinical Oncology’s (ASCO) annual conference is the largest meeting in the world focused on clinical oncology—typically attracting more than 35,000 attendees, including clinical and laboratory scientists and trainees, patient advocates, and representatives from the pharmac

The 55th annual meeting of the American Society of Clinical Oncology was held from May 31 through June 4 in Chicago. This year’s meeting included several updates in metastatic breast cancer research. Below are key highlights in this important field.